Trump Is Guilty of Pandemicide History will show the

New Post Public Reply Private Reply Replies (1) Message Board
Bhawks
286
Trump Is Guilty of Pandemicide

History will show the former U.S. president was staggeringly negligent during the pandemic’s deadly third wave.


BY LAURIE GARRETT | FEBRUARY 18, 2021, 5:00 PM

At long last, we see glimmers of hope. The COVID-19 epidemic in the United States has fallen below the numbers of daily new cases tallied on the eve of the presidential election, the point at which this viral nightmare soared. Using the New York Times’ coronavirus data tracker, on Nov. 1, 2020, there were 74,195 new cases counted in the country; by Feb. 16, new case reports came in at 64,376.

But in between those dates, a national horror unfolded, peaking on Jan. 8 with 300,619 new cases reported in just 24 hours. This staggering wave, one full year into the pandemic, was completely unnecessary for the world’s richest country. Achieving any sense of closure will require holding Donald Trump accountable for the failure.

There is vast evidence of Trump’s negligence during the pandemic’s third wave. Had I been a member of the House of Representatives during the body’s impeachment deliberations, I would have added to Trump’s indictment the crime of pandemicide, naming him as responsible for most of the COVID-19 deaths that transpired while he, the nation’s leader, was preoccupied with damning Joe Biden’s election victory.

Trump’s failure to, as he vowed in his oath of office, “faithfully execute the office of president of the United States” promulgated a scale of lives lost exceeding anything experienced in the country since the Civil War, 160 years ago.

I do not accuse Trump of pandemicide in reference to mistakes made by his administration between January 2020—when it generally ignored the outbreak in Wuhan, China—and the summer surge of cases and deaths across the United States.

I do not charge pandemicide over Trump’s Feb. 26, 2020, dismissal of the COVID-19 threat as miniscule, claiming, “The level that we’ve had in our country is very low, and those people are getting better, or we think that in almost all cases they’re better or getting. We have a total of 15.”

Nor do I charge pandemicide over his repeated insistence that COVID-19 cures were available in the forms of hydroxychloroquine, bleach, ultraviolet light, convalescent plasma therapy, the Regeneron cocktail, oleander extract, or simply warm weather.

And though there is striking evidence that the policies of the four-year Trump administration vastly worsened life expectancy and mortality rates in the United States, contributing to 461,000 excess deaths in 2018 alone, these are matters of callous, ill-considered policies and brutal budget cuts, preceding the virus’s arrival to U.S. shores.

Pandemicide is not the outcome of ill-advised, ignorant, or outright stupid budget actions and health messages. I do not even level the charge over Trump’s denunciation of mask use and opposition to temporary business and school closures to halt the spread of SARS-CoV-2, encouraging people to “liberate” states that were implementing tough lockdown regulations.

Rather, the path of pandemicide was paved in pursuit of the president’s reelection and his relentless, all-consuming post-election campaign to refute his opponent’s victory, claiming election fraud and even theft.

Despite the summer surge in COVID-19 infections nationwide, Trump abandoned virtual campaigning in favor of crowded, largely maskless gatherings of his supporters, knowingly risking that each rally would become a superspreader event. According to a study by Stanford University, 18 campaign rallies held between June 20 and Sept. 22, 2020, spawned in excess of 30,000 COVID-19 cases, likely leading to more than 700 deaths.

During the same time period, half of Trump’s campaign rallies were followed by COVID-19 surges in the counties in which they took place.

While Biden’s campaign rallies were largely virtual or held in parking areas with participants in their vehicles, Trump’s tightly packed, mostly mask-free throngs increased in both number and frequency, further spreading the virus and causing the U.S. government’s top COVID-19 response expert, Anthony Fauci, to warn that the president was “asking for trouble.”

Even after Trump and the first lady contracted COVID-19, compelling emergency treatment that included, in Trump’s case, hospitalization at Walter Reed National Military Medical Center and round-the-clock treatment from an army of physicians and nurses, the president refused to regularly don a mask.

On the day of his hospital admission, Oct. 2, the United States had cumulatively logged more than 200,000 deaths to COVID-19—an undercount, as are all U.S. COVID-19 numbers, but an official data point that would more than double by the Jan. 20 inauguration of Biden.

According to a new Lancet Commission report compiled by an international team of august scientists and public health leaders, some 40 percent of America’s COVID-19 death toll during the Trump administration was needless, meaning it could have been averted with available nonmedical interventions.

By the time the election took place, Trump had ignored the pandemic, not attending a single COVID-19 White House meeting for at least five months, since late May. Behind the scenes in the fall, the Trump administration lobbied Congress vigorously to block the movement of funds to states for vaccine rollout efforts, leaving them unable to efficiently execute mass immunizations.
.
And going forward from election night, on Nov. 3, to the inauguration on Jan. 20, Trump was fully fixated on overturning Biden’s victory. He ceased speaking to the press on Dec. 8, held no public events after Nov. 4, and made his final public appearance at a Dec. 12 football game.

According to White House schedules, Trump had few official meetings for days, left Washington for Mar-a-Lago on Dec. 23, and did not resurface until New Year’s Eve, when he delivered a video address to the nation celebrating Food and Drug Administration emergency approval of SARS-CoV-2 vaccines.

On Jan. 6, the president delivered his now infamous speech to supporters, exhorting them to march down Pennsylvania Avenue to the Capitol. From Jan. 7 until he moved out of the White House on the morning of Jan. 20, Trump made few public remarks, frustrated by his loss of access to social media.

As his much-touted Operation Warp Speed sputtered, unable to speed vaccines into the arms of Americans, Trump was silent. And the White House became COVID-19 central, with chief of staff Mark Meadows, four other White House staff, Secretary of Housing and Urban Affairs Ben Carson, and David Bossie, Trump’s designated leader of efforts to challenge the election, all infected.

In line with the president’s mantra that COVID-19 wasn’t all that serious—“Don’t let it take over your lives”— none of these individuals regularly wore protective face masks in the White House or on the election-counting trail.

So, I level the charge of pandemicide against Trump for his failure to say or do anything to halt the soaring burden of infection and death across the United States from Election Day to his departure from office.

During a period when experts inside his government warned that holiday travel and interactions over Thanksgiving, Christmas, and New Year’s could lead to massive spread of the virus, and states clamored for aid to disseminate vaccines, Trump was mum.

He ignored the pandemic on Nov. 3, when 92,000 people were newly infected, bringing the nation’s cumulative total to 9.4 million and its death toll to 225,000.

He remained taciturn as more than 1 million Americans per day, over the four-day Thanksgiving weekend, flew on commercial planes and millions more traveled by other means to visit families, despite stay-at-home pleas from the Centers for Disease Control and Prevention. By Nov. 30, more than 13.5 million Americans had tested positive for COVID-19, and 259,000 had died.

As Christmas approached, public health leaders again pleaded for Americans to resist temptation, stay home, and avoid family gatherings. By Dec. 22, 18 million Americans had acquired COVID-19, and 314,000 had died from it. But the president was silent, and, again, millions of Americans traveled and celebrated with friends and families.

As the new year neared, on Dec. 31, the total case count was almost 20 million, with 336,000 deaths. And still, Trump was silent.

As his insurrection mob gathered on Capitol Hill, the case tally topped 21 million, with 352,000 deaths.

And by the time Trump boarded Marine One for his final helicopter ride at taxpayer expense, en route to Mar-a-Lago, 24 million Americans had tested positive with SARS-CoV-2, killing nearly 400,000 of them.

Between the election and the inauguration, the number of infected Americans more than doubled, skyrocketing from 9.4 million cases to 24 million—adding some 15 million cases, on Trump’s watch, when he was fixated on overturning Biden’s victory and AWOL on the pandemic front.

And in his absence from pandemic duty—his duty to protect the American people—172,000 Americans died, nearly doubling the mortality toll since Election Day.

Republicans have, of course, decided that Trump cannot be impeached now that he is a private citizen. As a matter of formality, then, my call is moot.

But let history record that no sitting U.S. president—since April 30, 1789, when George Washington took the first oath on the balcony of Federal Hall on Wall Street in New York City—has willfully allowed such preventable carnage to unfold on the American people.

Let history record that Donald Trump is guilty of the crime of pandemicide.

https://foreignpolicy.com/2021/02/18/trump-is...ndemicide/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Technical Deep Dive into HONOR X9e Pro's Durability

Updated Category News Views 56

Rethinking Smartphone Power HONOR's latest device, the X9e Pro, flaunts an 11,000mAh battery—stuck it right behind a neat cover without making the thing feel like a brick. You'd think with a battery that big, they’d have to hire bodybuilders to lift it, but nope. At 8.08mm thick and weighing just 203g, this phone bucks the bulk. They’ve squeezed the power of a power...

Continue Reading
Photocure's Q3 2026: Revenue Plateau and CFO Shakeup

Updated Category News Views 111

The Bladder Cancer Scene: Steady as She Goes Sometimes, you look at numbers and find tranquility, like staring into still waters. That's the scene over at Photocure ASA with their latest Q3 results. Clocking in with revenues of NOK 134.2 million from their Hexvix®/Cysview® products, they're barely flinching from last year's NOK 134.1 million. Is it a victory or a...

Continue Reading
Ryde Group Faces Class Action: Key Investor Takeaways

Updated Category News Views 51

Ryde Group's Tumble: More Than Just Market Volatility When RYDE shares nosedived like a lead balloon, it wasn't due to a market hiccup—it was a darn mess fueled by alleged manipulation. At the heart of this crash are accusations of a blatant pump-and-dump scheme that allegedly swindled investors out of millions. Pump-and-Dump: The Dirty Mechanics This ain't your regular...

Continue Reading
Labcorp Lifts 2026 Guidance Amid Strong Q3 Performance

Updated Category News Views 96

Labcorp's Q3 Numbers Speak Loud and Clear Another quarter, another robust set of numbers for Labcorp (NYSE:LH). The company is strutting into the spotlight with third-quarter 2026 results that have investors nodding in approval. Revenue surged to $3.81 billion, marking a 6.9% increase from the prior year's $3.56 billion. And get this: adjusted EPS jumped 14.5%, clocking...

Continue Reading
Clip Expands Horizons with Pulpos Acquisition, New Board Member

Updated Category News Views 109

Clip's Strategic Move with Pulpos Clip just laid down a serious marker in the digital payment world by snagging Pulpos, a firm that’s got its claws deep into AI-driven business management software. This move isn't just some fancy headline. It's a real, grounded step in expanding Clip's ecosystem to bolster the backbone of Mexico's economy: small and medium-sized...

Continue Reading
Beta Bionics: Investors on Edge, Legal Moves Underway

Updated Category News Views 37

A Tumultuous Time for Beta Bionics Investors Trouble's brewing for those holding Beta Bionics, Inc. (NASDAQ: BBNX) shares. This isn't just market jitters—it's a full-blown legal tussle. The shareholder-rights law honchos at Johnson Fistel are sounding the alarms, and investors better heed their call before the clock strikes November 3, 2026. There's a class action...

Continue Reading
BAIC FOTON Builds Service Hub in South Africa

Updated Category News Views 28

There's something about seeing a company go all-in on a continent like Africa. This time, it's BAIC FOTON, putting down roots in South Africa with a spanking new training center. On October 27, just before their Africa Partners Conference, they opened up the BAIC FOTON Africa Regional Training Center. This move isn't just about bricks and mortar—it's about creating a...

Continue Reading
Raleigh's Auction Direct Stresses Oil Changes

Updated Category News Views 50

Keeping Engines Humming in Raleigh There's nothing quite like keeping an engine running like clockwork, especially in a place like Raleigh where folks rely on their rides day in and day out. That's where Auction Direct USA steps in, offering professional oil change services aimed at preserving the performance and reliability of used cars. A simple yet crucial service:...

Continue Reading
Elbit Systems Poised for Q3 2026 Earnings Reveal

Updated Category News Views 84

Elbit Systems: A Strategic Player in Defense Here's what's going on with Elbit Systems Ltd. (NASDAQ:ESLT), the Israeli defense heavy hitter. They're gearing up to spill the beans on their Q3 financial results this November 17th. And for those of us keeping an eye on how defense contractors are adapting to today's chaotic geopolitical climate, this is a date you don't want...

Continue Reading
Quarterra Taps Jeb Cox for Texas Development Leadership

Updated Category News Views 70

Big Moves in the Lone Star State Jeb Cox is stepping into some rather big cowboy boots over at Quarterra. With nearly two decades under his belt in the multifamily game, he's saddling up as the new Managing Director of Development in Texas. Quarterra, no stranger to the multifamily rodeo, wants to tighten its grip on the bustling Texas market. And Cox, with his gritty,...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Insurance with AI-Powered Smart Apps by DXC

Updated Category News Views 199

DXC Launches Assure Smart Apps for the Insurance Sector Empowering insurers with smart automation and AI is essential in modernizing operations, enhancing decision-making, and driving growth. DXC Technology (NYSE: DXC), a leading global technology services provider, has introduced the DXC Assure Smart Apps, a comprehensive suite of AI-powered applications designed to...

Continue Reading
AllianceBernstein Fund Updates Portfolio Composition Insight

Updated Category News Views 113

Insight into AllianceBernstein Global High Income Fund AllianceBernstein Global High Income Fund, Inc. (NYSE: AWF) has recently provided a detailed overview of its investment portfolio, highlighting the top fixed-income holdings and overall asset distribution. Understanding these details is key for investors aiming to navigate the complexities of high-yield investments...

Continue Reading
Biden's Administration Takes Passive Stance on Port Labor Negotiations

Updated Category News Views 75

Insights on the Biden Administration's Strategy for Port Negotiations In a noteworthy shift, officials from President Joe Biden's administration are adopting a passive approach in the ongoing labor talks at major East and Gulf Coast ports in the U.S. An unnamed official shared details about this hands-off strategy during recent remarks. The Stalemate in Labor Negotiations...

Continue Reading
Exploring the Expansion of the 3D Cell Culture Market to USD 4 Billion

Updated Category News Views 117

Understanding the Surge in the 3D Cell Culture Market The global market for 3D Cell Culture is witnessing a remarkable growth trajectory, fueled by the increasing emphasis on innovative drug development and effective disease modeling. Current insights reveal that this market, valued at USD 1.4 billion as of 2023, is anticipated to reach an impressive USD 4.0 billion by...

Continue Reading
Walt Farrell Takes Charge as CEO of Atlanta Gas Light and Chattanooga Gas

Updated Category News Views 316

Walt Farrell Appointed as President and CEO at Southern Company Gas Southern Company Gas is excited to announce the appointment of Walt Farrell as the new president and chief executive officer for Atlanta Gas Light and Chattanooga Gas. This transition will take effect at the end of this month, marking a significant development for the company. Future Responsibilities for...

Continue Reading